During Wednesday’s Afternoon trade, Shares of Manulife Financial Corporation (USA) (NYSE:MFC), gain 1.95% to $17.75.
Manulife Financial Corporation declared that its U.S. Division (John Hancock Financial) has successfully accomplished its formerly declared reinsurance transaction through which New York Life has assumed, on a reinsurance basis, a net 60 percent interest in John Hancock’s in-force participating life insurance closed block, which was written prior to John Hancock’s demutualization in 2000. John Hancock will continue to service the policies and there will be no change in contract terms or policyholder benefits as a result of the reinsurance.
The reinsurance transaction was declared on December 23, 2014, together with a contract under which John Hancock would acquire New York Life’s Retirement Plan Services (RPS) business. The acquisition of the Retirement Plans Services business closed on April 14, 2015.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States. It offers various individual life and health insurance, and individual and group long-term care insurance products through insurance agents, brokers, banks, financial planners, and direct marketing.
Shares of Nordic American Tanker Ltd (NYSE:NAT), declined -1.49% to $15.18, during its Afternoon trading session.
Nordic American Offshore Ltd. declared that its Board of Directors has declared a dividend of $0.17 per common share for the 2nd quarter 2015. This is the same as for the previous quarter for this newly established company which was stock listed on NYSE June 12, 2014. The payment of dividend is predictable to take place on or about August 19, 2015 to shareholders of record as of August 5, 2015.
Nordic American Tankers Limited, a tanker company, engages in acquiring and chartering double-hull tankers. As of December 31, 2014, it owned 24 Suezmax crude oil tankers, counting two new buildings under construction. The company was founded in 1995 and is based in Hamilton, Bermuda.
Radian Group Inc (NYSE:RDN), during its Wednesday’s Afternoon trading session gained 0.43% to $18.52.
Radian Group Inc. (RDN) stated net income for the quarter ended June 30, 2015, of $50.0 million, or $0.22 per diluted share, which comprised of the following pre-tax items: a loss of $91.9 million on induced conversion and debt extinguishment from recent actions to strengthen the company’s capital structure, and net gains of $28.4 million on investments and other financial instruments. This compares to net income for the quarter ended June 30, 2014, of $174.8 million, or $0.78 per diluted share, which comprised of pre-tax net gains of $25.3 million on investments and other financial instruments, and $71.3 million of net income from suspended operations. The company also stated an income tax provision of $34.8 million for the quarter ended June 30, 2015, contrast to an income tax benefit of $10.7 million for the quarter ended June 30, 2014.
Radian Group Inc., through its auxiliaries, provides mortgage and real estate products and services in the United States. It operates through two segments, Mortgage Insurance, and Mortgage and Real Estate Services (MRES). The Mortgage Insurance segment provides credit-related insurance coverage, principally through private mortgage insurance that protects mortgage lenders from all or a portion of default-related losses on residential mortgage loans made to home buyers, in addition to facilitates the sale of these mortgage loans in the secondary mortgage market. It offers primary mortgage insurance coverage on residential first-liens.
Finally, Cardinal Health Inc (NYSE:CAH), decreased -0.10%, to $83.60.
Cardinal Health Inc (CAH) declared the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction using existing cash and new debt.
Headquartered in Livonia, Mich., The Harvard Drug Group had revenues of about $450 million in 2014. There are 450 employees and two distribution facilities comprised of in the transaction.
In addition to enhancing the company’s generic pharmaceutical distribution business, the acquisition expands Cardinal Health’s existing telesales programs and capabilities; broadens the company’s portfolio of over-the counter pharmaceutical products; and brings specialized packaging offerings to meet the needs of hospital systems and other institutions.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
